Chlorpyrifos Lawsuits

Chlorpyrifos lawsuits allege that repeated exposure to this widely used insecticide can contribute to Parkinson’s disease. The people most likely to bring these claims are farmers, pesticide applicators, pest control workers, groundskeepers, greenhouse employees, and others who personally mixed, loaded, sprayed, or cleaned up chlorpyrifos products over months or years.

Chlorpyrifos was sold under trade names that include Dursban, Lorsban, Cobalt, Nufos, Bolton, Stallion, Pilot, Warhawk, and Hatchet. It was used on farms, golf courses, ornamental plants, and residential and commercial properties. Many workers remember the trade name but not the active ingredient. Product identification is therefore one of the first and most important parts of investigating a claim.

If you have Parkinson’s disease after years of working with pesticides, you may have wondered whether that exposure played a role. A December 2025 study gives lawyers and scientists a serious reason to investigate chlorpyrifos. Researchers associated estimated long-term residential exposure near agricultural applications with more than 2.5 times the risk of Parkinson’s disease. They also found Parkinson’s-related brain damage in mice that inhaled chlorpyrifos.

Our lawyers are investigating claims for people who directly handled chlorpyrifos and were later diagnosed with Parkinson’s disease or qualifying Parkinsonism. These cases are new, and difficult questions about exposure and medical causation remain. But people who spent years working with these products deserve a careful investigation of what they used, what the manufacturers knew, and whether the exposure contributed to their disease.

Our lawyers are reviewing these claims. Call 800-553-8082 or contact Miller & Zois online for a free consultation.

Latest Chlorpyrifos Lawsuit Updates

If you directly handled chlorpyrifos and were later diagnosed with Parkinson’s disease, call our lawyers at 800-553-8082 or contact us online. The consultation is free.

Do You Qualify?

A strong case begins with evidence that you personally handled chlorpyrifos and later received a qualifying diagnosis. You may not remember every product name or date today. That is common when the work happened decades ago. Employment records, pesticide logs, invoices, labels, and former coworkers may help identify what you used and how often you used it.

Exposure histories vary. A farmer who mixed Lorsban during several planting seasons has a different history from a person who walked through a treated field once. A pest control technician who filled tanks with Dursban, worked around leaking hoses, and cleaned application equipment may have a strong factual account even if old purchase records are gone.

We are not accepting indirect exposure cases. The new epidemiological study estimated exposure from agricultural applications near homes and workplaces. That research is useful for deciding whether chlorpyrifos deserves serious attention as a Parkinson’s risk factor. A lawsuit presents a narrower question. Can this plaintiff prove meaningful exposure to a product sold by this defendant? Direct handling gives the case a firmer foundation.

Parkinson’s Disease and Parkinsonism Are Not Identical

Parkinson’s disease is a progressive neurological disorder. Common symptoms include tremor, muscle rigidity, slow movement, impaired balance, changes in speech and handwriting, sleep problems, and eventually cognitive impairment. The diagnosis is clinical. A neurologist considers the pattern and progression of symptoms, the examination, treatment response, and whether another condition better explains the problems.

Parkinsonism describes a group of movement symptoms rather than one disease. It can result from Parkinson’s disease, another neurological disorder, certain medications, strokes, or other causes. Our firm may review a Parkinsonism case when a physician has prescribed Parkinson’s medication and the records show that the medication is helping. Treatment response is part of our intake criteria, while a neurologist’s diagnosis and the complete medical record remain essential.

Exposure and Diagnosis May Be Decades Apart

Parkinson’s disease does not ordinarily appear the day after pesticide exposure. The disease process may develop quietly for years before tremor, stiffness, or slow movement sends someone to a doctor. That makes latency a central issue. A long interval between exposure and diagnosis does not automatically defeat a claim, but the timeline must make medical sense.

There is no court-approved chlorpyrifos latency rule. Experts will have to consider when exposure began, how long it continued, when early symptoms appeared, when the diagnosis was made, and whether age, genetics, other pesticides, head trauma, medications, or another condition offer a stronger explanation.

Chlorpyrifos Products and Direct Exposure

Chlorpyrifos is the active ingredient. It may not be the name you remember seeing in large letters on a jug, bag, drum, or invoice. Dow introduced the chemical commercially in 1965 and sold it under different names for agricultural and residential markets. Other formulators and registrants later sold chlorpyrifos products of their own.

Other chlorpyrifos trade names have included Pilot, Warhawk, Hatchet, Lock On, and additional regional or specialized products. That list is not proof that a particular container contained chlorpyrifos in the year you used it. Product formulations, registrations, distributors, and corporate ownership changed. The label and EPA registration number are better evidence than a product name alone.

Raid alone does not meet our criteria. Raid is a brand used for many products containing different active ingredients. A person who remembers only “Raid” cannot assume it was chlorpyrifos. If Raid was one of several products and you also handled an identifiable chlorpyrifos product, the separate chlorpyrifos exposure can still be evaluated.

Jobs With Potential Chlorpyrifos Exposure

Direct exposure may have occurred among people who worked as:

• Farm owners, farmworkers, crop consultants, and licensed pesticide applicators
• Orchard, vineyard, citrus, cotton, corn, soybean, wheat, and alfalfa workers
• Pest control technicians and termite treatment workers
• Golf course superintendents, groundskeepers, and turf management employees
• Greenhouse, nursery, landscaping, and ornamental plant workers
• Workers who mixed pesticides, filled tanks, repaired sprayers, or cleaned equipment
• Mosquito control and public health pesticide workers
• Homeowners who personally applied an identifiable residential chlorpyrifos product before 2000

What Direct Handling Looks Like

The strongest exposure histories often involve opening concentrate, measuring it, pouring it into a tank, stirring mixtures, carrying a backpack sprayer, driving an open-cab tractor during application, clearing clogged nozzles, fixing leaking hoses, washing tanks, disposing of containers, or cleaning up a spill. Skin contact and inhalation are both relevant routes. Chlorpyrifos can enter the body through breathing, swallowing, or skin contact.

Protective equipment can reduce exposure, but work conditions rarely match a label perfectly. Gloves tear, respirators fit poorly, and workers sometimes remove them in hot weather. Concentrate can also splash during mixing. An investigation should focus on the equipment actually used and what happened during the work.

What Does the Science Show?

Pesticide exposure has been associated with Parkinson’s disease for years. The harder scientific job is identifying which chemical contributes to the risk. Farmworkers rarely encounter only one pesticide. Exposure may have occurred decades before diagnosis, and researchers ordinarily cannot measure a chemical in someone’s body after that much time.

Earlier studies supplied clues rather than a complete case for chlorpyrifos. A 2014 study of ambient organophosphate exposure in California reported an association between Parkinson’s disease and estimated exposure to organophosphates near homes and workplaces. Laboratory studies also examined whether chlorpyrifos could injure dopamine systems, alter genes connected to Parkinson’s pathways, produce inflammation, or cause movement changes. The evidence was suggestive, but it left room for a familiar defense argument: an association involving a pesticide class does not prove that one product causes one disease.

The December 2025 study moved the discussion forward because it focused on chlorpyrifos and used human, mouse, and zebrafish evidence in the same project. The UCLA Parkinson’s Environment and Genes cohort included 829 people with Parkinson’s disease and 824 controls from Kern, Fresno, and Tulare counties in California. Researchers geocoded lifetime residential and workplace addresses and compared them with state pesticide use reports for chlorpyrifos applications within 500 meters.

The study adjusted for estimated exposure to paraquat, diazinon, and glyphosate. Long-term residential chlorpyrifos exposure remained associated with more than 2.5 times the risk of developing Parkinson’s disease. This adjustment helps because it reduces the chance that the reported association merely reflects exposure to another commonly used pesticide. It does not eliminate every possible confounding factor.

What the Human Study Does Not Prove

The researchers estimated ambient exposure from reported agricultural applications. They did not measure the amount of chlorpyrifos absorbed into each participant’s body. A 500-meter model cannot recreate the wind on a particular day, whether a window was open, whether a worker wore gloves, whether concentrate spilled, or whether the same person used other pesticides that were not fully captured.

The reported 2.5-fold association applies to the population studied. It cannot predict whether a directly exposed worker will develop Parkinson’s disease or prevail in a lawsuit.

Why the Animal Findings Help Plaintiffs

Researchers exposed mice to aerosolized chlorpyrifos for six hours per day, five days per week, for eleven weeks. The animals developed impaired movement, loss of dopamine neurons, activation of brain immune cells, and abnormal alpha-synuclein. Each finding is relevant to the biology of Parkinson’s disease.

The zebrafish experiments helped show how the chemical may damage cells. Chlorpyrifos interfered with the cells’ ability to clear damaged material and toxic proteins, a process connected to Parkinson’s disease. When researchers restored that cleanup system or reduced the troublesome proteins, the neurons became less vulnerable.

Acute Poisoning and Parkinson’s Disease Are Different Claims

Chlorpyrifos is an organophosphate insecticide that inhibits acetylcholinesterase. Acute poisoning can overstimulate the nervous system and cause sweating, excessive saliva, nausea, vomiting, abdominal cramps, muscle twitching, weakness, confusion, breathing problems, seizures, paralysis, or death. These immediate effects are well recognized.

A Parkinson’s claim may involve a worker who never suffered a dramatic poisoning episode. The alleged harm comes from repeated exposure and progressive damage involving dopamine-producing neurons. Many potential plaintiffs therefore have no emergency room record tied to a particular day of spraying.

What Manufacturers and Regulators Knew

The history matters because a failure to warn case is not limited to what scientists know today. Plaintiffs will ask what manufacturers knew or should have known while people were mixing and spraying their products. They will also ask whether companies reported adverse events, conducted adequate chronic neurotoxicity research, and changed warnings as evidence accumulated.

The 1995 reporting penalty deserves attention without exaggeration. EPA stated that DowElanco submitted 249 incident reports late and had failed to report certain incidents learned through personal injury claims and lawsuits. Plaintiffs may argue that the episode shows why adverse event reporting is critical and why company files deserve scrutiny. Defendants can respond that the reported conditions were varied and did not establish that chlorpyrifos causes Parkinson’s disease. Discovery should reveal more about what the companies knew and how they responded.

How Can You Prove Exposure Decades Later?

Most people do not save pesticide receipts for thirty years. Many workers did not choose the products or see the invoice. The employer bought the chemicals, a supervisor handed out the work, and everyone went home. Missing receipts make the investigation harder, although other records and witnesses may still identify the product.

Do not worry if you cannot remember every detail right now. Start with what you do remember: employers, properties, crops or buildings treated, container colors, product names, equipment, protective gear, spills, and the people who worked beside you. Our investigators can look for old employment records, purchase invoices, pesticide use reports, applicator files, and spraying logs.

A recognizable trade name, repeated hands-on use, consistent dates, witnesses, and records from the employer or application site can make the exposure history much stronger. Even a partial memory may give an investigator a useful place to begin.

Legal Claims Against the Manufacturers

Corporate buyouts mean the company responsible today may have a different name from the one printed on a bottle decades ago. Dow sold products that included Dursban, Lorsban, and Cobalt, and its agricultural business later became Corteva. FMC acquired Cheminova, which had sold products including Nufos and Bolton. Our lawyers handle the work of tracing the product and identifying the company that may be financially responsible.

Failure to Warn About Parkinson’s Risk

Plaintiffs allege that manufacturers sold chlorpyrifos without adequately warning that repeated exposure could increase the risk of Parkinson’s disease. An acute poisoning warning is not necessarily a warning about a neurodegenerative disease that may appear years later. A worker who knows a product can make him sick if swallowed may still have no reason to understand that routine inhalation or skin exposure could allegedly contribute to Parkinson’s disease.

The defendants will challenge whether a Parkinson’s warning was scientifically justified during the years of exposure. That puts the knowledge timeline at the center of the case. Plaintiffs will look for toxicology studies, adverse event reports, internal communications, proposed label language, communications with EPA, and decisions about additional testing.

Design Defect and Negligence

Design defect claims may argue that foreseeable chronic neurological risks outweighed the product’s benefits or that safer alternatives were available for particular uses. Negligence claims may focus on testing, monitoring, reporting, label revisions, and continued promotion. State law differs significantly on how these claims are evaluated. A theory that works under one state’s law may fail under another’s.

Concealment and Punitive Damages

Plaintiffs allege that manufacturers concealed the relationship between chlorpyrifos and chronic neurological harm and fought to protect the market. Punitive damages require more than proving injury. Plaintiffs ordinarily must show conscious or reckless disregard of a known danger under the governing state law. The 1995 reporting penalty may justify deeper discovery, but it does not by itself prove a Parkinson’s coverup.

Federal Preemption Will Be a Major Defense

Pesticide labels are regulated under the Federal Insecticide, Fungicide, and Rodenticide Act. Manufacturers frequently argue that federal law preempts state claims demanding warnings that EPA did not approve. Plaintiffs will respond that FIFRA does not give a manufacturer permission to sell a misbranded product, that state duties can parallel federal requirements, and that manufacturers have continuing reporting and labeling obligations.

Courts have not yet resolved those arguments in a chlorpyrifos Parkinson’s case. The outcome may depend on the claims pleaded, the state law involved, the historical label, what evidence was available at the time, and what regulatory steps a manufacturer could have taken. This will not be a side issue. It may decide which claims reach a jury.

Expected Causation Defenses

Manufacturers will emphasize that Parkinson’s disease is multifactorial and often has no identifiable single cause. They will point to age, family history, other pesticide exposures, head injuries, and medical conditions. They will challenge the exposure reconstruction and argue that epidemiological estimates do not reveal the dose absorbed by an individual plaintiff.

The strongest cases will combine a recognized product, repeated direct handling, a credible chronology, corroborating records or witnesses, a well-documented diagnosis, and experts who can address reasonable alternative causes.

Chlorpyrifos Lawsuit Settlement Amounts

We know why people search for chlorpyrifos settlement amounts. Parkinson’s disease can create years of medical expenses, lost income, home care, and uncertainty for an entire family. No publicly reported chlorpyrifos Parkinson’s settlement, verdict, bellwether trial, settlement matrix, or MDL has established claim values.

Even at this early stage, our lawyers believe many successful claims could eventually fall between $300,000 and $800,000. That is our preliminary projection based on the seriousness and long-term cost of Parkinson’s disease. It is not an average drawn from resolved chlorpyrifos cases. The range could change substantially after courts evaluate the expert testimony and discovery shows what the manufacturers knew.

The strongest cases may have substantially greater trial value when the plaintiff was diagnosed at a younger age, can document heavy exposure, has major wage loss, and needs extensive future care. A multimillion-dollar verdict is possible in a serious product liability case, but it should not be presented as the expected result of a chlorpyrifos claim. Trial value and settlement value are different, and neither can be calculated from the diagnosis alone.

The Paraquat Parkinson’s litigation provides general lessons about expert battles, exposure proof, and Parkinson’s damages. It is not a settlement calculator for chlorpyrifos because Paraquat is a different chemical with different manufacturers, scientific literature, labels, and defenses. Still, those cases will likely resolve before these cases and those values will be a marker for this litigation.

Filing Deadlines and Statutes of Limitations

Every state limits the time available to file a product liability lawsuit. The difficult question is when that period began. A person may have been diagnosed with Parkinson’s disease years before learning that chlorpyrifos was a possible cause. Plaintiffs may argue that the deadline did not begin until they knew or reasonably should have known of a potential connection between the product and the disease.

Manufacturers will press for an earlier date. They may rely on the diagnosis, older pesticide research, medical records mentioning chemical exposure, regulatory publicity, or earlier lawyer advertising. Some states also have statutes of repose that can bar a claim after a fixed period measured from sale or exposure, even if the disease and its possible cause were discovered later.

The December 2025 study does not automatically restart every limitations period. If you have Parkinson’s disease and directly handled chlorpyrifos, waiting for an MDL or settlement announcement may jeopardize a claim. A lawyer can examine the deadline under the law that applies to your case.

Frequently Asked Questions

What is chlorpyrifos?

Chlorpyrifos is an organophosphate insecticide first registered in the United States in 1965. It kills insects by inhibiting acetylcholinesterase and disrupting normal nerve signaling. It was used in agriculture, pest control, termite treatment, turf management, mosquito control, and residential applications.

Does chlorpyrifos cause Parkinson’s disease?

A 2025 study associated estimated long-term residential exposure near agricultural chlorpyrifos applications with more than 2.5 times the risk of Parkinson’s disease. The same research produced Parkinson’s-related damage in animal models and identified a possible explanation for how the chemical harms brain cells. Courts have not yet decided whether this evidence is sufficient to establish general causation in a chlorpyrifos Parkinson’s lawsuit.

Is chlorpyrifos the same pesticide as paraquat?

No. Chlorpyrifos is an organophosphate insecticide. Paraquat is an herbicide used to kill weeds. Both have been studied in connection with Parkinson’s disease, but they are different chemicals sold by different companies.

How much exposure does your firm require?

Our current minimum is listed in the complete case criteria above, along with the product, timing, and diagnosis requirements.

Does living near a farm qualify?

Not under our firm’s current criteria. The epidemiological research on nearby agricultural applications is important, but our firm is reviewing claims involving people who personally handled chlorpyrifos.

Can I qualify if I do not remember the product name?

Possibly, if records or witnesses provide a credible path to identifying chlorpyrifos. Employment files, pesticide use reports, invoices, applicator records, photographs, former coworkers, and the crop or property treated may help. A general memory of using pesticides is unlikely to be enough without some way to identify chlorpyrifos.

Does exposure to Raid qualify?

Raid-only exposure does not qualify under our current criteria. Raid has been used for many formulations and active ingredients. If you also directly handled an identifiable chlorpyrifos product, our lawyers can evaluate that exposure separately.

Can someone diagnosed with Parkinsonism bring a claim?

Our firm will review a Parkinsonism claim when a physician has prescribed Parkinson’s medication. We will need the neurology records and a clear direct exposure history. Medication response alone does not prove chlorpyrifos causation.

Are there chlorpyrifos Parkinson’s settlements?

No publicly reported settlement has established an average. Our settlement analysis explains our preliminary projection and the evidence that will move a future claim higher or lower.

Is there a chlorpyrifos Parkinson’s MDL or class action?

There is no chlorpyrifos Parkinson’s MDL or certified class action. A personal injury class action would face problems because exposure, diagnosis, causation, damages, and state law differ from person to person. If many similar federal cases are filed, lawyers may later ask for coordinated multidistrict litigation.

What should I gather before calling a lawyer?

Write down product names, employers, locations, crops or properties treated, years of use, application methods, protective equipment, spills, and witnesses. Gather neurology records, medication lists, employment documents, applicator licenses, photographs, labels, and purchase records. Do not discard an old container or alter any record.